Supernus Pharmaceuticals
SUPN
$56.55
Share price
-2.18%
Change (1 day)
4.61%
Change (1 year)
Categories
Supernus Pharmaceuticals (SUPN) - Total debt
Total debt on the balance sheet as of December 2024 : NZ$59.95 Million
According to Supernus Pharmaceuticals 's latest financial reports the company's total debt is NZ$59.95 Million. A company’s total debt is the sum of all current and non-current debts.
Supernus Pharmaceuticals - Total debt on balance sheet (from 2009 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | NZ$60.76 M | -7.46% |
| 2023-12-31 | NZ$65.66 M | -90.63% |
| 2022-12-31 | NZ$0.70 B | 12.05% |
| 2021-12-31 | NZ$0.62 B | 8.87% |
| 2020-12-31 | NZ$0.57 B | 2.19% |
| 2019-12-31 | NZ$0.56 B | 14.4% |
| 2018-12-31 | NZ$0.49 B | |
| 2017-12-31 | N/A | -100% |
| 2016-12-31 | NZ$6.01 M | -41.92% |
| 2015-12-31 | NZ$10.35 M | -69.07% |
| 2014-12-31 | NZ$33.46 M | -20.03% |
| 2013-12-31 | NZ$41.85 M | 50.37% |
| 2012-12-31 | NZ$27.83 M | -26.33% |
| 2011-12-31 | NZ$37.78 M | -61.14% |
| 2010-12-31 | NZ$97.21 M | -5.85% |
| 2009-12-31 | NZ$0.10 B | -20.1% |
| 2008-12-31 | NZ$0.12 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |
 | NZ$0.52 B | 775.38% | 🇺🇸 USA |
 | NZ$58.85 B | 98,071.05% | 🇺🇸 USA |
 | NZ$89.56 B | 149,297.45% | 🇺🇸 USA |
 | NZ$26.27 B | 43,730.06% | 🇺🇸 USA |
 | NZ$64.08 B | 106,795.04% | 🇺🇸 USA |